Evidence map›Paper›PMID 41008964›Full record

ArticleAntioxidants (Basel, Switzerland)2025

Synthetic Cyclic C

Edina Pandur, Gergely Gulyás-Fekete, Győző Kulcsár, Imre Huber

Abstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Edina PandurDepartment of Pharmaceutical Biology, Faculty of Pharmacy, University of Pécs, Rókus str. 4, H-7624 Pécs, Hungary.ORCID 0000-0001-5012-3242
Gergely Gulyás-FeketeDepartment of Biochemistry and Medical Chemistry, Medical School, University of Pécs, Szigeti str. 12, H-7624 Pécs, Hungary.
Győző KulcsárInstitute of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Pécs, Rókus str. 4, H-7624 Pécs, Hungary.ORCID 0000-0002-4098-1072
Imre HuberInstitute of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Pécs, Rókus str. 4, H-7624 Pécs, Hungary.

Funding

János Bolyai Research Scholarship of the Hungarian Academy of Sciences BO/00251/24/5
6 · The paper itself

Abstract

Parkinson's disease (PD) is recognized as one of the most common neurodegenerative disorders globally. The primary factor contributing to this condition is the loss of dopaminergic neurons, which results in both motor and nonmotor symptoms. The etiology of neurodegeneration remains unclear. However, it is characterized by the elevated production of reactive oxygen species, which subsequently leads to oxidative stress, lipid peroxidation, mitochondrial dysfunction, and inflammation. The investigation of the applicability of natural compounds and their derivatives to various diseases is becoming increasingly important. The possible role of curcumin from

Indexed as

antioxidantapoptosiscyclic chalconesinflammationoxidative stressParkinson’s diseasesynthetic cyclic C5-curcuminoids

Identifiers

PMID41008964
PMCPMC12466566

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.